Recently, Henselet al. demonstrated that EWS/FLI expression levels are significantly reduced in Ewing sarcoma cell lines following treatment with the BET (bromo and extraterminal) inhibitor JQ143. Here, EWSR1 is linked to Ewing sarcoma.